Search
Stoke Therapeutics Inc
STOKAdd to Watchlist
26.110USD
0.0000.00%
Close 09-23 16:00（ET）
1.63BMarket Cap
LossP/E TTM
Pre-market 08:52 (ET)25.800USD-0.310-1.19%
Pre-market 08:52 (ET)Stoke Therapeutics Inc (STOK) Stock Price Target & Forecast
Analyst Rating
Based on 14 analysts giving stock ratings to Stoke Therapeutics Inc in the past month.
Buy
6 Strong Buy
8 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
47.000USD+60.96%
STOK Analyst Recommendation Trends
In the current month, STOK has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. STOK average Analyst price target in the last month is 47.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
6
6
6
6
6
6
6
4
8
8
6
6
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
14
12
12
12
12
12
10
STOK Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, STOK EPS is projected to reach -0.929 in FY2026Q3, following reported EPS of -0.933 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.71
-0.83
-0.80
-0.93
-0.98
Actual
-0.98
-0.79
-0.93
--
--
Surprise
-37.09%
+4.12%
-17.37%
--
--
FAQs
What is Stoke Therapeutics Inc's expected revenue for the next quarter?
Stoke Therapeutics Inc's expected revenue is 8.18M.
What is Stoke Therapeutics Inc's price target?
Analysts forecast that Stoke Therapeutics Inc's price target is USD 47.00, with the highest forecast at USD 60.00 and the lowest forecast at USD 35.00.
How have Stoke Therapeutics IncSTOK's recent earnings per share performed?
The market expectation was USD -0.93, while Stoke Therapeutics IncSTOK's earnings per share (EPS) for the previous quarter was USD -0.79. EPS for the next quarter is expected at USD -0.93.
What is the analyst rating for Stoke Therapeutics Inc?
Based on the ratings of Stoke Therapeutics Inc's stock from 14 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.